Samuel Klempner, MD, Oncology, Boston, MA, Massachusetts General Hospital

SamuelJacobKlempnerMD

Oncology Boston, MA

Gastrointestinal Cancer

GI Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School

Dr. Klempner is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Klempner's full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical CenterFellowship, Hematology/Oncology, 2010 - 2013
  • Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2010
  • University of Massachusetts Medical SchoolClass of 2007
  • Hamilton CollegeB.A., Magna Cum Laude, 2003

Certifications & Licensure

  • ME State Medical License
    ME State Medical License 2021 - 2022
  • CA State Medical License
    CA State Medical License 2013 - 2020
  • MA State Medical License
    MA State Medical License 2010 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Standing Ovation Award Cedars-Sinai Medical Center, 2016
  • SuperDoctors Southern CA Rising Star 2016-2017
  • Top Physician Communicator UC Irvine, 2015
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • PD-1 as an emerging target in gastric cancer: current evidence  
    Tran PN, Sarkissian S, Chao J, Klempner SJ, Gastrointestinal Cancer: Targets and Therapy, 1/1/2017
  • Moving Molecular Subtypes to the Clinic in Gastric Cancer  
    Chao J, Lee J, Klempner SJ, Transl Cancer Res, 1/1/2016
  • ROS1 (c-ros oncogene 1)  
    Klempner SJ, Ou, SH, Atlas Genet Cytogenet Oncol Haematol, 1/1/2014

Books/Book Chapters

Abstracts/Posters

  • Neoadjuvant Chemotherapy Improves Survival In Patients With Clinical T4b Colon Cancer.
    Dehal A, Graff-Baker AN, Voung B, Fischer T, Klempner SJ, et al, Digestive Disease Week, Chicago, IL, 1/6/2017
  • A Phase 1 Study of LY3022855 (A Colony-Stimulating Factor-1 receptor [CSF-1R] inhibitor) in Patients (pts) With Advanced Solid Tumors
    Dowlati A, Rugo HS, et al, ASCO, 1/1/2017
  • Comprehensive genomic profiling (CGP) of esophageal and tubular GI tumors identifies differing frequencies of ErbB family member amplifications with therapeutic implic...
    Bailey M, Ali SM, Schrock AB, Klempner SJ, George B, Lipson D, et al, GI ASCO, 1/1/2017
  • Join now to see all

Lectures

  • DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival. 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
  • Early Is Better: The Roles of Prevention, Screening, and Early Detection 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
  • Help From Within: DNA to Personalized Therapy for Gastric Cancer 
    1/18/2017
  • Join now to see all

Other

  • Navigating the complexity of cancer with tumor mutational burden (TMB). 
    Klempner SJ, Oncology Times
    1/1/2017
  • Advancing precision medicine in colorectal cancer. 
    Klempner SJ, Pharma Letter
    1/1/2017

Authored Content

  • Immunotherapies as a Targeted Therapy to Accelerate Personalized CareFebruary 2020
  • Immunotherapies as a Targeted Therapy to Accelerate Personalized CareFebruary 2020

Press Mentions

  • Hope for Stomach Cancer Will Host a Webinar on November 7 to Help Raise Awareness of This Deadly Disease and Share Effective Late-Stage Treatments
    Hope for Stomach Cancer Will Host a Webinar on November 7 to Help Raise Awareness of This Deadly Disease and Share Effective Late-Stage TreatmentsOctober 20th, 2020
  • Solid Tumors Respond to VEGF/Checkpoint Inhibitor Combo
    Solid Tumors Respond to VEGF/Checkpoint Inhibitor ComboJuly 18th, 2019
  • New Combination Shows Early Promise in Gastric Cancer
    New Combination Shows Early Promise in Gastric CancerJuly 18th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations